Home >  Search by Antibiotics > Hygromycin

Hygromycin

 
Cell line Species Tissue Culture medium Cencentration
293 human kidney; fetal Dulbecco's modified Eagle's medium 200 (μg/ml)
293 human kidney; fetal Eagle's minimal essential medium 200 (μg/ml)
P4-2 pig Minimal essential medium 150 (μg/ml)
P4-2 pig Minimal essential medium 400 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 400 (μg/ml)
A549 human Lungcarcinoma RPMI 1640 Medium 300 (μg/ml)
3T3-L1 mouse embryo Dulbecco's modified Eagle's medium 200 (μg/ml)
HOS TK- human Dulbecco's modified Eagle's medium 150 (μg/ml)
A9 mouse/mouse hybridoma Dulbecco's modified Eagle's medium 200 (μg/ml)
U-2 OS human bone; osteosarcoma Dulbecco's modified Eagle's medium 100 (μg/ml)
AtT-20 mouse pituitary tumor Dulbecco's modified Eagle's medium 400 (μg/ml)
GLUTag Dulbecco's modified Eagle's medium 450 (μg/ml)
REG RPMI 1640 Medium 200 (μg/ml)
HEK-D2 Dulbecco's modified Eagle's medium 100 (μg/ml)
Hep G2 human liver; hepatocellular carcinoma RPMI 1640 Medium 100 (μg/ml)
NEC Dulbecco's modified Eagle's medium 500 (μg/ml)
Hep3B Dulbecco's modified Eagle's medium 200 (μg/ml)
BEL-7402 Dulbecco's modified Eagle's medium 600 (μg/ml)
BJAB RPMI 1640 Medium 600 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 600 (μg/ml)
Bosc23 Dulbecco's modified Eagle's medium 100 (μg/ml)
NIH3T3 mouse embryo Dulbecco's modified Eagle's medium 100 (μg/ml)
B95-8 RPMI 1640 Medium 200 (μg/ml)
B95-8 200 (μg/ml)
HBL-100 150 (μg/ml)
A9 mouse/mouse hybridoma 100 (μg/ml)
G-401 human kidney; rhabdoid tumor Dulbecco's modified Eagle's medium 400 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 200 (μg/ml)
A9 mouse/mouse hybridoma Dulbecco's modified Eagle's medium 100 (μg/ml)
HCD-57 Dulbecco's modified Eagle's medium 800 (μg/ml)
BD EcoPack2-293 Dulbecco's modified Eagle's medium 100 (μg/ml)
3T3-L1 mouse embryo Dulbecco's modified Eagle's medium 200 (μg/ml)
3T3-L1 mouse embryo Dulbecco's modified Eagle's medium 110 (μg/ml)
AR42J rat exocrine pancreas; tumor 200 (μg/ml)
SK-BR-3 human pleural effusion (metastasis); adenocarcinoma (colon primary) Dulbecco's modified Eagle's medium 100 (μg/ml)
HCC Dulbecco's modified Eagle's medium 400 (μg/ml)
CHO-K1 hamster, Chinese ovary Eagle's minimal essential medium 100 (μg/ml)
AtT-20 mouse pituitary tumor Dulbecco's modified Eagle's medium 200 (μg/ml)
BRL 3A rat liver Dulbecco's modified Eagle's medium 100 (μg/ml)
BRL 3A rat liver Dulbecco's modified Eagle's medium 100 (μg/ml)
HCT 116 human colon; colorectal carcinoma Dulbecco's modified Eagle's medium 350 (μg/ml)
Hep G2 human liver; hepatocellular carcinoma Dulbecco's modified Eagle's medium 350 (μg/ml)
LNCaP human prostatic adenocarcinoma RPMI 1640 Medium 200 (μg/ml)
JAR human placenta; choriocarcinoma RPMI 1640 Medium 150 (μg/ml)
BALB/3T3 clone A31 mouse embryo Dulbecco's modified Eagle's medium 500 (μg/ml)
HBL-100 RPMI 1640 Medium 200 (μg/ml)
NIH/3T3 mouse embryo Dulbecco's modified Eagle's medium 200 (μg/ml)
BALB/3T3 clone A31 mouse embryo Dulbecco's modified Eagle's medium 200 (μg/ml)
3T3 mouse embryonic fibroblast Dulbecco's modified Eagle's medium 150 (μg/ml)
F9 mouse testis; embryonic carcinoma; testicular teratoma Dulbecco's modified Eagle's medium 600 (units/ml)
BHK-21 (C-13) hamster, Syrian golden kidney 200 (μg/ml)
Akata RPMI 1640 Medium 300 (μg/ml)
BL RPMI 1640 Medium 300 (μg/ml)
Bing human kidney; amphotropic retroviral packaging line Dulbecco's modified Eagle's medium 200 (μg/ml)
3T3-L1 mouse embryo Dulbecco's modified Eagle's medium 200 (μg/ml)
Caco-2 human colon; colorectal adenocarcinoma RPMI 1640 Medium 2 (mg/ml)
Caco-2 human colon; colorectal adenocarcinoma DMEM + F12 medium 200 (μg/ml)
Caco-2 human colon; colorectal adenocarcinoma Dulbecco's modified Eagle's medium 75 (μg/ml)
MDCK (NBL-2) dog kidney Minimal essential medium 75 (μg/ml)
Caco-2 human colon; colorectal adenocarcinoma Dulbecco's modified Eagle's medium 200 (μg/ml)
Caco-2 human colon; colorectal adenocarcinoma Dulbecco's modified Eagle's medium 175 (μg/ml)
PA317 mouse embryo; amphotropic retroviral packaging line RPMI 1640 Medium 100 (μg/ml)
A549 human Lungcarcinoma RPMI 1640 Medium 200 (μg/ml)
A-431 human epidermis; epidermoid carcinoma Dulbecco's modified Eagle's medium 200 (μg/ml)
NAMALWA human B lymphocyte; Burkitt's lymphoma Dulbecco's modified Eagle's medium 210 (μg/ml)
A-431 human epidermis; epidermoid carcinoma Dulbecco's modified Eagle's medium 200 (μg/ml)
HeLa human cervix; adenocarcinoma Minimal essential medium 500 (μg/ml)
HO-15 α-modified minimal essential medium 100 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 300 (μg/ml)
CHO hamster, Chinese ovary Minimal essential medium 200 (μg/ml)
BHK-21 (C-13) hamster, Syrian golden kidney Eagle's minimal essential medium 80 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 250 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 200 (μg/ml)
Jurkat, Clone E6-1 human T lymphocyte; acute T cell leukemia RPMI 1640 Medium 250 (μg/ml)
PA317 mouse embryo; amphotropic retroviral packaging line Dulbecco's modified Eagle's medium 400 (μg/ml)
BALB/3T3 Dulbecco's modified Eagle's medium 250 (μg/ml)
HEp-2 human HeLa contaminant Dulbecco's modified Eagle's medium 60 (μg/ml)
A-431 human epidermis; epidermoid carcinoma Dulbecco's modified Eagle's medium 700 (μg/ml)
H9 hES DMEM + F12 medium 100 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 200 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 50 (μg/ml)
CHO-K1 hamster, Chinese ovary Dulbecco's modified Eagle's medium 300 (μg/ml)
GH3 rat pituitary tumor Dulbecco's modified Eagle's medium 200 (μg/ml)
GH3 rat pituitary tumor Dulbecco's modified Eagle's medium 400 (units/ml)
Jurkat, Clone E6-1 human T lymphocyte; acute T cell leukemia RPMI 1640 Medium 300 (μg/ml)
GH3 rat pituitary tumor Dulbecco's modified Eagle's medium 1000 (μg/ml)
hESCs RPMI 1640 Medium 1 (μg/ml)
NIH3T3 mouse embryo 1 (μg/ml)
LS 174T human colon; colorectal adenocarcinoma RPMI 1640 Medium 50 (μg/ml)
GH3 rat pituitary tumor Dulbecco's modified Eagle's medium 500 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 400 (μg/ml)
SH-SY5Y human bone marrow (metastasis); neuroblastoma (brain primary) 400 (μg/ml)
C2C12 mouse muscle Dulbecco's modified Eagle's medium 400 (μg/ml)
JAR human placenta; choriocarcinoma Dulbecco's modified Eagle's medium 200 (μg/ml)
CHO hamster, Chinese ovary 1 (mg/ml)
AA8 hamster, Chinese ovary α-modified minimal essential medium 1 (mg/ml)
JEG-3 human placenta; choriocarcinoma 1.6 (μg/ml)
293 human kidney; fetal Dulbecco's modified Eagle's medium 500 (μg/ml)
T-47D human pleural effusion (metastasis); ductal carcinoma (mammary gland primary) DMEM / F 12 medium 300 (μg/ml)
293 human kidney; fetal 100 (μg/ml)
BJAB Dulbecco's modified Eagle's medium 1 (μg/ml)
A-431 human epidermis; epidermoid carcinoma Dulbecco's modified Eagle's medium 500 (μg/ml)
HCC1937 human mammary gland; primary ductal carcinoma RPMI 1640 Medium 200 (μg/ml)
WEHI-231 mouse B lymphocyte; lymphoma Iscove's modified Dulbecco's medium 1.6 (μg/ml)
BL RPMI 1640 Medium 300 (μg/ml)
C2C12 mouse muscle Dulbecco's modified Eagle's medium 150 (μg/ml)
G355-5 cat brain; astrocyte Dulbecco's modified Eagle's medium 150 (μg/ml)
293T human Kidney (embryonic) 400 (μg/ml)
Jurkat, Clone E6-1 human T lymphocyte; acute T cell leukemia 40 (μg/ml)
Jurkat, Clone E6-1 human T lymphocyte; acute T cell leukemia RPMI 1640 Medium 150 (μg/ml)
CHO-K1 hamster, Chinese ovary Dulbecco's modified Eagle's medium 150 (μg/ml)
293T human Kidney (embryonic) Dulbecco's modified Eagle's medium 250 (μg/ml)
HUVEC Dulbecco's modified Eagle's medium 200 (μg/ml)
Jurkat, Clone E6-1 human T lymphocyte; acute T cell leukemia RPMI 1640 Medium 50 (μg/ml)
Jurkat, Clone E6-1 human T lymphocyte; acute T cell leukemia RPMI 1640 Medium 500 (μg/ml)
U-937 human macrophage; histiocytic lymphoma RPMI 1640 Medium 200 (μg/ml)
NIH/3T3 mouse embryo Dulbecco's modified Eagle's medium 400 (μg/ml)
NRK rat kidney 260 (μg/ml)
NIH/3T3 mouse embryo Dulbecco's modified Eagle's medium 150 (IU/ml)
Neuro-2a mouse brain; neuroblast; neuroblastoma Dulbecco's modified Eagle's medium 400 (μg/ml)
Neuro-2a mouse brain; neuroblast; neuroblastoma Dulbecco's modified Eagle's medium 200 (μg/ml)
293T human Kidney (embryonic) 200 (μg/ml)
COS-7 monkey, African green kidney Dulbecco's modified Eagle's medium 400 (μg/ml)
293 human kidney; fetal 100 (μg/ml)
COLO 320DM human colon; colorectal adenocarcinoma Dulbecco's modified Eagle's medium 400 (μg/ml)
HeLa human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 100 (μg/ml)
CHO hamster, Chinese ovary DMEM / F 12 medium 300 (μg/ml)
CHO-K1 hamster, Chinese ovary Ham’s F-12 nutrient mixture 250 (μg/ml)
HeLa human cervix; adenocarcinoma RPMI 1640 Medium 400 (μg/ml)
CHO hamster, Chinese ovary Ham’s F-12 nutrient mixture 150 (μg/ml)
HeLa S3 human cervix; adenocarcinoma Dulbecco's modified Eagle's medium 600 (μg/ml)
MDA-MB-435 human breast Minimal essential medium 200 (μg/ml)
AKH12 Dulbecco's modified Eagle's medium 200 (μg/ml)
AtT-20/D16–8 Dulbecco's modified Eagle's medium 200 (μg/ml)
N2a Dulbecco's modified Eagle's medium 600 (μg/ml)
NS0 6A1 GMEM medium 1000 (μg/ml)
CSM14.1 420 (units/ml)
EUFA592 RPMI 1640 Medium 100 (μg/ml)
PANC-1 human pancreas (duct); epithelioid carcinoma Minimal essential medium 200 (μg/ml)
HCT 116 human colon; colorectal carcinoma Dulbecco's modified Eagle's medium 200 (μg/ml)
Rat2 rat fetus Dulbecco's modified Eagle's medium 800 (μg/ml)
Hep G2 human liver; hepatocellular carcinoma Dulbecco's modified Eagle's medium 200 (μg/ml)
CD18/HPAF DMEM / F 12 medium 200 (μg/ml)
1180MEL RPMI 1640 Medium 150 (μg/ml)
A549 human Lungcarcinoma RPMI 1640 Medium 150 (IU/ml)
HNSCC Dulbecco's modified Eagle's medium 150 (μg/ml)
BTI-TN-5B1-4 150 (μg/ml)
βTC-3 Dulbecco's modified Eagle's medium 200 (μg/ml)
AtT-20/D16v-F2 mouse pituitary tumor Dulbecco's modified Eagle's medium 300 (μg/ml)
βHC-13 Dulbecco's modified Eagle's medium 100 (μg/ml)
βTC-3 Dulbecco's modified Eagle's medium 200 (μg/ml)
7721 RPMI 1640 Medium 200 (μg/ml)
MCF-7C4-12 Minimal essential medium 50 (μg/ml)
T47D-Y Minimal essential medium 200 (μg/ml)
L929 Eagle's minimal essential medium 400 (μg/ml)
OB-6 α-modified minimal essential medium 300 (μg/ml)
RAW264 RPMI 1640 Medium 500 (μg/ml)
MSU 1.0 Dulbecco's modified Eagle's medium 100 (μg/ml)
43.2.1DR4 RPMI 1640 Medium 100 (μg/ml)
F36P RPMI 1640 Medium 100 (μg/ml)
BFC012 Dulbecco's modified Eagle's medium 100 (μg/ml)
BU-11 RPMI 1640 Medium 100 (μg/ml)
AB2.2 100 (μg/ml)
R503 Dulbecco's modified Eagle's medium 100 (μg/ml)
HRL9 600 (units/ml)
BL21(DE3)pLysS Rosetta 2 250 (μg/ml)
COS-7 monkey, African green kidney Dulbecco's modified Eagle's medium 200 (μg/ml)
PANC-1 human pancreas (duct); epithelioid carcinoma Dulbecco's modified Eagle's medium 40 (μg/ml)
CHO hamster, Chinese ovary Dulbecco's modified Eagle's medium 0.5 (μg/ml)
CH7C17 RPMI 1640 Medium 400 (μg/ml)
CL1-5 RPMI 1640 Medium 300 (μg/ml)
 
 
 
This project is supported byTOKU-Ewhich specializes in manufacturing ultra-pure antibiotics for a broad spectrum of biotechnology applications as well as for the pharmaceutical industry. TOKU-E is a global leader in biotechnology innovation, offering great benefits and applications to the biopharmaceutical and diagnostic industries as well as for biotechnology research communities.
 Cell-Lines | Plasmids | Privacy Policy | Terms of Use | About Us | Contact Us
Cell-Culture Database Version 1.1